These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25649613)

  • 1. Knockdown of PKM2 Enhances Radiosensitivity of Non-small cell Lung Cancer.
    Wang S; Ma Y; Wang P; Song Z; Liu B; Sun X; Zhang H; Yu J
    Cell Biochem Biophys; 2015 Sep; 73(1):21-6. PubMed ID: 25649613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting pyruvate kinase M2 contributes to radiosensitivity of non-small cell lung cancer cells in vitro and in vivo.
    Meng MB; Wang HH; Guo WH; Wu ZQ; Zeng XL; Zaorsky NG; Shi HS; Qian D; Niu ZM; Jiang B; Zhao LJ; Yuan ZY; Wang P
    Cancer Lett; 2015 Jan; 356(2 Pt B):985-93. PubMed ID: 25444918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.
    Yuan S; Qiao T; Zhuang X; Chen W; Xing N; Zhang Q
    Yonsei Med J; 2016 Nov; 57(6):1312-23. PubMed ID: 27593857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular compartmentalization of PKM2 identifies anti-PKM2 therapy response in vitro and in vivo mouse model of human non-small-cell lung cancer.
    Suzuki A; Puri S; Leland P; Puri A; Moudgil T; Fox BA; Puri RK; Joshi BH
    PLoS One; 2019; 14(5):e0217131. PubMed ID: 31120964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells.
    Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J
    Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells.
    Zhou CF; Li XB; Sun H; Zhang B; Han YS; Jiang Y; Zhuang QL; Fang J; Wu GH
    IUBMB Life; 2012 Sep; 64(9):775-82. PubMed ID: 22807066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced radiosensitivity of non-small-cell lung cancer (NSCLC) by adenovirus-mediated ING4 gene therapy.
    Ling C; Xie Y; Zhao D; Zhu Y; Xiang J; Yang J
    Cancer Gene Ther; 2012 Oct; 19(10):697-706. PubMed ID: 22863759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new pyruvate kinase M2 isoform (PKM2) activator for the treatment of non-small-cell lung cancer (NSCLC).
    Li RZ; Fan XX; Shi DF; Zhu GY; Wang YW; Luo LX; Pan HD; Yao XJ; Leung EL; Liu L
    Chem Biol Drug Des; 2018 Nov; 92(5):1851-1858. PubMed ID: 29931766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells.
    Kang J; Kim W; Kwon T; Youn H; Kim JS; Youn B
    Oncotarget; 2016 Apr; 7(17):23961-74. PubMed ID: 27004408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model.
    Guo W; Zhang Y; Chen T; Wang Y; Xue J; Zhang Y; Xiao W; Mo X; Lu Y
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):65-72. PubMed ID: 20336315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The small-molecule CDK inhibitor, SNS-032, enhances cellular radiosensitivity in quiescent and hypoxic non-small cell lung cancer cells.
    Kodym E; Kodym R; Reis AE; Habib AA; Story MD; Saha D
    Lung Cancer; 2009 Oct; 66(1):37-47. PubMed ID: 19193471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missense mutations in pyruvate kinase M2 promote cancer metabolism, oxidative endurance, anchorage independence, and tumor growth in a dominant negative manner.
    Iqbal MA; Siddiqui FA; Chaman N; Gupta V; Kumar B; Gopinath P; Bamezai RN
    J Biol Chem; 2014 Mar; 289(12):8098-105. PubMed ID: 24492614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing of pkm2 increases the efficacy of docetaxel in human lung cancer xenografts in mice.
    Shi HS; Li D; Zhang J; Wang YS; Yang L; Zhang HL; Wang XH; Mu B; Wang W; Ma Y; Guo FC; Wei YQ
    Cancer Sci; 2010 Jun; 101(6):1447-53. PubMed ID: 20507318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant overexpression of pyruvate kinase M2 is associated with aggressive tumor features and the BRAF mutation in papillary thyroid cancer.
    Feng C; Gao Y; Wang C; Yu X; Zhang W; Guan H; Shan Z; Teng W
    J Clin Endocrinol Metab; 2013 Sep; 98(9):E1524-33. PubMed ID: 23846818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-15a/16 enhances radiation sensitivity of non-small cell lung cancer cells by targeting the TLR1/NF-κB signaling pathway.
    Lan F; Yue X; Ren G; Li H; Ping L; Wang Y; Xia T
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):73-81. PubMed ID: 25442346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.
    Dai Y; Liu Y; Li J; Jin M; Yang H; Huang G
    Bioengineered; 2022 May; 13(5):13906-13918. PubMed ID: 35706397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate kinase M2 contributes to cell growth in gastric cancer via aerobic glycolysis.
    Li H; Xu H; Xing R; Pan Y; Li W; Cui J; Lu Y
    Pathol Res Pract; 2019 Jun; 215(6):152409. PubMed ID: 31000383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation-induced radioresistance is mediated by ROS-dependent inactivation of protein phosphatase 1 in non-small cell lung cancer cells.
    Kim W; Youn H; Kang C; Youn B
    Apoptosis; 2015 Sep; 20(9):1242-52. PubMed ID: 26033480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
    Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level.
    Chen S; Wang H; Ng WL; Curran WJ; Wang Y
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1524-9. PubMed ID: 22014955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.